Bingchuan Wei

Bingchuan Wei describes how to cultivate a culture of innovation and calculated risk-taking while operating within the compliance demands of biopharmaceutical drug development.

Bingchuan Wei shares practical guidance for early-career scientists seeking to transition into industry drug development across diverse therapeutic modalities.

Bingchuan Wei reflects on how to connect high-level patient and medical goals to the highly technical analytical tools required to meaningfully support ADC drug development decisions.

Bingchuan Wei discusses how robust ADC characterization strategies meet regulatory expectations and how stronger methodologies can accelerate candidate selection to clinical approval.

Bingchuan Wei identifies the toughest unresolved analytical challenges in ADC development and highlights the emerging technologies he sees as most capable of closing those gaps.

Bingchuan Wei of Genentech explains how HIC-MS integrates separation and mass detection to resolve and quantify individual DAR species with greater precision than standalone HIC or MS alone.

Professor Mary Wirth and graduate students Bingchuan Wei and Benjamin Rogers from Purdue University demonstrate a quantum leap in protein column efficiency. Using colloidal silica particles of submicrometer diameters (470 nm), they obtained plate heights that were as much as 15-fold lower than the theoretical limit for Hagen-Poiseuille flow.